Je Goun, Arora Swati, Raithatha Shyamsundar, Barrette Ryan, Valizadeh Navid, Shah Utkarsh, Desai Devangi, Deb Anindita, Desai Soaham
Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Department of Extension Programmes, Charutar Arorgya Mandal, Shree Krishna Hospital, Bhaikaka University, Anand, India.
Neuroepidemiology. 2021;55(3):188-195. doi: 10.1159/000515030. Epub 2021 May 5.
In India, there have been only few published studies of Parkinson's disease (PD) showing a wide range of prevalence. We conducted this study to determine the prevalence of PD in the rural population of Gujarat, in the western region of India.
This cross-sectional descriptive study was conducted in the villages of Anand, a district of Gujarat, India, between September 2019 and February 2020. This study used a multistep approach including a screening questionnaire and video recording followed by clinical examination by a neurologist, laboratory evaluation, and brain imaging to evaluate patients with PD.
A total population of 18,896 was screened. The overall crude prevalence of PD was 42.3 per 100,000, and the prevalence over the age of 60 was 308.9 per 100,000 which showed the trend of increasing disease prevalence with age. Their mean duration of illness was 39.3 ± 27.3 months, and more than half of patients with PD had multiple associated nonmotor symptoms and nearly one-third had comorbid anxiety or depression. Environmental factors are important in the pathogenesis of PD, but there was no clear association between patients with PD and certain variables including consumption of well water, exposure to pesticides or other toxins, smoking cigarettes, and drinking alcohol or coffee in our study.
The present study showed the current epidemiological data of PD from Gujarat, in western India. Further studies across different regions in India need to be encouraged for better understanding of PD prevalence in the Indian population.
在印度,仅有少数关于帕金森病(PD)的已发表研究,其患病率范围广泛。我们开展这项研究以确定印度西部古吉拉特邦农村人口中帕金森病的患病率。
这项横断面描述性研究于2019年9月至2020年2月在印度古吉拉特邦阿南德区的村庄进行。本研究采用多步骤方法,包括筛查问卷和视频记录,随后由神经科医生进行临床检查、实验室评估和脑成像,以评估帕金森病患者。
共筛查了18896人。帕金森病的总体粗患病率为每10万人42.3例,60岁以上人群的患病率为每10万人308.9例,显示出疾病患病率随年龄增长的趋势。他们的平均病程为39.3±27.3个月,超过一半的帕金森病患者有多种相关的非运动症状,近三分之一的患者合并焦虑或抑郁。环境因素在帕金森病的发病机制中很重要,但在我们的研究中,帕金森病患者与某些变量之间没有明显关联,这些变量包括饮用井水、接触杀虫剂或其他毒素、吸烟以及饮酒或咖啡。
本研究展示了印度西部古吉拉特邦帕金森病的当前流行病学数据。需要鼓励在印度不同地区开展进一步研究,以更好地了解印度人群中帕金森病的患病率。